Last week, we finally saw a proposed rule – “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation” arrive at OMB. We expect that this proposed rule will avert the current end of telehealth prescribing flexibility on December 31, 2024. However, there remains significant risk [...]
Over 380 clinicians and practitioners signed a letter, requesting the DEA to issue a revised proposed rule to regulate the prescribing of controlled substances through telehealth as soon as possible to ensure adequate time for patients to continue existing care. To read a full copy of the stakeholder letter, please click here. [...]
FOR IMMEDIATE RELEASE Stakeholders Send Letter to DEA Urging Action on Telehealth Rule Crucial for Mental Health, Substance Use Disorders WASHINGTON, DC, APRIL 2, 2024 – The Alliance for Connected Care, American Telemedicine Association, ATA Action, the Consumer Technology Association, and the Healthcare Information and Management Systems Society, co-leading the effort, submitted a letter [...]
The Alliance for Connected Care joined over 45 organizations in a statement to the Drug Enforcement Administration (DEA), requesting explicit guidance to the pharmacy community that the geography of a prescriber in relation to the patient or the pharmacy should not be a "red flag" when a prescription is a result of a telehealth [...]
The Alliance for Connected Care appreciated the opportunity to testify for the Drug Enforcement Administration's (DEA) listening session on prescribing controlled substances via telemedicine on September 12, 2023. We appreciate the DEA’s quick response during the COVID-19 public health emergency (PHE) to allow prescribing via telemedicine. This was also a hugely meaningful expansion of access [...]
Over 35,000 Americans provided comments on the Drug Enforcement Administration's (DEA) proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." In comment letters responding to the DEA's proposed rule, hundreds of key stakeholders highlighted the need for a special registration for telemedicine and [...]
The Alliance for Connected Care and other leading organizations called on the Biden Administration to make modifications to the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, to ensure more flexible prescribing limitations for providers when a controlled [...]
The Alliance for Connected Care submitted comments in response to the request for information from the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. The Alliance highlights its concerns that the rule does not satisfy multiple congressional [...]
Alliance Joins Letter With Mental Health Groups Calling on DEA for Continued Access to Treatments Through Telehealth
Krista Drobac, executive director of the Alliance for Connected Care, was featured in The Hill. See below for an excerpt: Clock is still ticking on virtual mental health prescribing Congress acted last month to extend important telehealth flexibilities that will ensure millions of Americans and their providers will continue to [...]